InvestorsHub Logo
Followers 13
Posts 483
Boards Moderated 0
Alias Born 03/11/2014

Re: uksausage post# 77844

Thursday, 09/20/2018 1:10:51 PM

Thursday, September 20, 2018 1:10:51 PM

Post# of 85904
Spot on post UK. The only reason I could see them being in a hurry to uplist is easier access to and better structured financing. If i'm holding restricted shares I'd feel alot better when they are in a NASDAQ listed company trading above $4. I also don't think the customers they work with really like be associated with an OTC pink company. Maybe getting listed on the NASDAQ might open the door for SGSI to start naming customers in their pr's of contracts. Its not uncommon for OTC stocks working with large companies to be under NDA. As far as dilution from the next acquisitions I am using their past acquisition costs/structure to get an idea of how many shares might be issued. Here's what I am lookin at.

ADEX was a $20mil revenue company and they used $2mil in convertible debt to finance half of the purchase. The next company they are targeting is in the $15-20mil range so if they use $2mil in convertible debt at .50c per share its only 4mil shares. Ofcourse ADEX were bought from a stuggling company so the terms of their next acquisition may be different. Curious to here your thoughts on this.

Thanks,

kz